Medical Properties Trust Inc. (NYSE:MPW) went down by -0.23% from its latest closing price compared to the recent 1-year high of $24.13. The company’s stock price has collected 2.38% of gains in the last five trading sessions. The Wall Street Journal reported on 03/31/22 that Hospital Deal Gone Bust Puts Real-Estate Firm in Spotlight
Is It Worth Investing in Medical Properties Trust Inc. (NYSE :MPW) Right Now?
Medical Properties Trust Inc. (NYSE:MPW) scored a price-to-earnings ratio above its average ratio, recording 9.16 x from its present earnings ratio. Plus, the 36-month beta value for MPW is at 0.77. Opinions of the stock are interesting as 6 analysts out of 14 who provided ratings for Medical Properties Trust Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 7 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $19.43, which is $2.66 above the current price. MPW currently public float of 593.73M and currently shorts hold a 7.23% ratio of that float. Today, the average trading volume of MPW was 6.67M shares.
MPW’s Market Performance
MPW stocks went up by 2.38% for the week, with a monthly jump of 12.64% and a quarterly performance of -6.47%, while its annual performance rate touched -18.21%. The volatility ratio for the week stands at 2.37% while the volatility levels for the past 30 days are set at 2.43% for Medical Properties Trust Inc. The simple moving average for the period of the last 20 days is 6.90% for MPW stocks with a simple moving average of -13.66% for the last 200 days.
Analysts’ Opinion of MPW
Many brokerage firms have already submitted their reports for MPW stocks, with Credit Suisse repeating the rating for MPW by listing it as a “Neutral.” The predicted price for MPW in the upcoming period, according to Credit Suisse is $17 based on the research report published on July 14th of the current year 2022.
JP Morgan, on the other hand, stated in their research note that they expect to see MPW reach a price target of $18, previously predicting the price at $24. The rating they have provided for MPW stocks is “Neutral” according to the report published on June 22nd, 2022.
Jefferies gave a rating of “Hold” to MPW, setting the target price at $20 in the report published on April 22nd of the current year.
MPW Trading at 4.84% from the 50-Day Moving Average
After a stumble in the market that brought MPW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.72% of loss for the given period.
Volatility was left at 2.43%, however, over the last 30 days, the volatility rate increased by 2.37%, as shares surge +9.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.08% lower at present.
During the last 5 trading sessions, MPW rose by +2.38%, which changed the moving average for the period of 200-days by -15.48% in comparison to the 20-day moving average, which settled at $16.17. In addition, Medical Properties Trust Inc. saw -27.21% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at MPW starting from HAMNER R STEVEN, who sale 285,000 shares at the price of $21.04 back on Apr 07. After this action, HAMNER R STEVEN now owns 1,961,214 shares of Medical Properties Trust Inc., valued at $5,996,400 using the latest closing price.
Aldag Edward K JR, the Chairman, President & CEO of Medical Properties Trust Inc., sale 615,000 shares at $21.33 during a trade that took place back on Mar 30, which means that Aldag Edward K JR is holding 3,497,206 shares at $13,117,950 based on the most recent closing price.
Stock Fundamentals for MPW
Current profitability levels for the company are sitting at:
- +67.24 for the present operating margin
- +76.67 for the gross margin
The net margin for Medical Properties Trust Inc. stands at +42.33. Equity return is now at value 13.20, with 5.70 for asset returns.